[1]
Govindarajan, R. et al. 2022. EE2: 3,4-Diaminopyridine Phosphate for AAL- The EEDAPP-ALS Trial. RRNMF Neuromuscular Journal. 3, 1 (Mar. 2022), 34–62. DOI:https://doi.org/10.17161/rrnmf.v3i1.16747.